PRKACB and colorectal carcinoma: The results outlined that low expression of PRKACB in tumor tissues was considerably associated with poor disease-free survival (log rank P = 0.0025, Figure 3A) and overall survival (log rank P = 0.0186, Figure 3B) in patients with CRC.